Abstract
The incidence of regional lymph node (LN) involvement in patients with prostate cancer depends on several factors like the tumor size and the Gleason score (GS). The risk of LN involvement is <10% in low-risk disease. A number of models were developed in order to predict the risk of LN involvement which helps the physicians to decide whether to perform a staging lymphadenectomy or LN irradiation. In this chapter, we will review the current guidelines for the delineation of lymphatic target volumes in prostate cancer.
| Original language | English |
|---|---|
| Title of host publication | Principles and Practice of Urooncology |
| Subtitle of host publication | Radiotherapy, Surgery and Systemic Therapy |
| Publisher | Springer International Publishing |
| Pages | 263-272 |
| Number of pages | 10 |
| ISBN (Electronic) | 9783319561141 |
| ISBN (Print) | 9783319561134 |
| DOIs | |
| Publication status | Published - 1 Aug 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Guidelines for the delineation of lymphatic target volumes in prostate cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver